Cadeler A/S and Eneti Inc. Announce Launch of Share Exchange Offer for All of The Outstanding Shares of Common Stock of Eneti Inc.

Stock Information for TCR2 Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TCR2 Therapeutics Inc.

Eneti Inc. and Cadeler A/S Share Exhange Offer Expiration Date is December 14, 2023
Cadeler A/S and Eneti Inc. Announce Extension of Share Exchange Offer for all Outstanding Shares of Common Stock of Eneti Inc. to December 14, 2023 & New Loan Facility
Cadeler A/S and Eneti Inc. Announce Extension of the Share Exchange Offer for All Outstanding Shares of Common Stock of Eneti Inc. to December 14, 2023 and New Loan Facility
Eneti Inc. Announces Closing of a $436.0 Million Credit Facility and Sale of Two NG2500X Vessels
Eneti Inc. Announces Financial Results for the Third Quarter of 2023 and Declares a Quarterly Cash Dividend
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JVA, NETI, SMMF, RPT
ENETI INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Eneti Inc. - NETI
Eneti Inc. to Announce Third Quarter 2023 Results and Have a Conference Call on November 14, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.